Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Revision: v3.5.0 to the record history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded a new site revision entry v3.4.3 and removed the previous v3.4.2 entry from the history.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedA new version entry dated 2026-02-13 was added, with QC status 'Has Not Concluded', and the record history now displays additional sections such as Adverse Events, Outcome Measures, Baseline Characteristics, and Participant Flow.SummaryDifference0.9%

- Check46 days agoChange DetectedAdded a new history entry: Revision: v3.4.2. The deletions remove the funding notice and the prior Revision: v3.4.1 entry.SummaryDifference0.5%

- Check53 days agoChange DetectedThe History now shows 'Results Submitted' with Revision 3.4.1, replacing the previous 'No Results Posted' (Revision 3.4.0). A government funding notice about the site's operation is displayed.SummaryDifference0.5%

- Check60 days agoChange DetectedThe history page adds a glossary toggle, uses color-coded indicators for additions and deletions, and updates the revision label from v3.3.4 to v3.4.0.SummaryDifference0.6%

Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.